Agilon Health Deadline: AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm

Core Viewpoint - Agilon Health, Inc. is facing a securities fraud lawsuit initiated by the Rosen Law Firm, with a lead plaintiff deadline set for March 2, 2026, for investors who purchased securities between February 26, 2025, and August 4, 2025 [1] Group 1: Lawsuit Details - The lawsuit alleges that Agilon's management made false and misleading statements regarding the company's financial guidance for 2025, which they knew was unattainable due to industry challenges [1] - It is claimed that Agilon overstated the positive financial impact from strategic actions taken to mitigate risks, leading to materially false representations about the company's business and prospects [1] - Investors are encouraged to join the class action without incurring out-of-pocket fees, as the Rosen Law Firm operates on a contingency fee basis [1] Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [1] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [1] - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise in handling such cases [1]